Optoceutics
Advancing non-invasive light technologies, based on gamma light therapy, to stimulate the brain and improve cognitive function.
- dt and ls
- horizon europe
- woman founder
- spinout
- eit ecosystem
- mental health
- neurology
- digital care
- eit health
- tech for patients
- non-invasive medical devices and treatments
- eit supernovas
- tech for biotech and pharma
- optical technology
- headstart (eit health)
- digital therapeutics
- headstart 2019 (eit health)
- neuromodulation and neurostimulation
- alzheimers disease
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
€50.0k | Support Program | ||
| Total Funding | 000k | ||
| DKK | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
OptoCeutics, founded in 2018 by CEO Dr. Ngoc Mai Nguyen and Jes Broeng, operates within the neurotechnology and wellness sector. The company was established to develop non-invasive light technologies aimed at improving cognitive function.
The founders' journey began with a shared vision to harness light to modulate brain activity. Dr. Nguyen's scientific background and leadership have been central to the company's direction, fostering a culture of research and development in collaboration with academic institutions like the University of California, Berkeley.
OptoCeutics' primary product is the EVY LIGHT®, a device that administers 40 Hz light therapy. This technology is designed to stimulate the brain's gamma waves non-invasively, with the objective of enhancing brain health and potentially counteracting cognitive decline associated with conditions such as Alzheimer's disease. The business model is centered on the sale of this light-based device to individuals seeking to proactively manage their cognitive health. The company collaborates with clinical and institutional partners to conduct trials and further validate its technology.
Keywords: neurotechnology, light therapy, cognitive function, brain health, Alzheimer's, 40 Hz stimulation, non-invasive, wellness technology, medical device, gamma waves